Literature DB >> 25468583

Internal jugular veins must be measured before catheterization.

Dorota Czyzewska1, Andrzej Ustymowicz2, Juliusz Kosel3.   

Abstract

STUDY
OBJECTIVE: The study objective is to determine the cross-sectional area (CSA) of the right and left internal jugular vein (IJV) in supine position in healthy subjects.
DESIGN: This is a prospective, nonrandomized study.
SETTING: The setting is a university hospital. PATIENTS: The patients are 185 consenting healthy subjects.
INTERVENTIONS: B-mode ultrasonography examinations of the right and left IJV were performed with the use of a linear 14-MHz transducer at the level of the cricoid cartilage. The CSA of the examined vessels was measured in a supine position.
MEASUREMENTS AND MAIN RESULTS: The CSA on both sides differed by up to 850%. There were no statistically significant differences between CSA of IJVs in men and women. The CSA of the IJV on the right side was significantly greater than on the left side. The right IJV was more often classified as the "dominant" vessel (CSA being more than twice as large as the opposite side). A "small" vessel (CSA ≤ 0.4 cm(2)) was found in 54 cases (14.6%). In 9 subjects (4.9%), they were detected bilaterally.
CONCLUSION: The CSA of IJVs varies widely. Although the CSA was found to be often greater on the right than on the left side, a "small" vessel may occur on both sides.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cannulation; Internal jugular vein; Ultrasound

Mesh:

Year:  2014        PMID: 25468583     DOI: 10.1016/j.jclinane.2014.09.010

Source DB:  PubMed          Journal:  J Clin Anesth        ISSN: 0952-8180            Impact factor:   9.452


  1 in total

1.  Effects of Venous Angioplasty on Cerebral Lesions in Multiple Sclerosis: Expanded Analysis of the Brave Dreams Double-Blind, Sham-Controlled Randomized Trial.

Authors:  Paolo Zamboni; Roberto Galeotti; Fabrizio Salvi; Alessia Giaquinta; Carlo Setacci; Salvatore Alborino; Giuseppe Guzzardi; Salvatore J Sclafani; Elisa Maietti; Pierfrancesco Veroux
Journal:  J Endovasc Ther       Date:  2019-11-17       Impact factor: 3.487

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.